Exosens Raises 2026 EBITDA Guidance to €192M on Image Intensifier Tube Ramp
Question
Exosens Raises 2026 EBITDA Guidance to €192M on Image Intensifier Tube Ramp
Direct answer
Defense optoelectronics manufacturer Exosens increased its 2026 operational guidance, projecting annual revenues between €558 million and €570 million against prior guidance of €520 million to €540 million. Full-year adjusted EBITDA expectations were raised to €186-192 million. The upward adjustment stems from rapid industrial scaling of high-performance image intensifier tube production lines alongside sustained defense customer orders, confirming robust European and allied military optronics procurement demand.
- Original publisher
- Market Ontology
- Evidence through
- 2026-09-17
- Published
- 2026-10-20
- Revision
- 1 · 2026-10-20
Cite as: Market Ontology, “Exosens Raises 2026 EBITDA Guidance to €192M on Image Intensifier Tube Ramp”, revision 1, evidence through 2026-09-17. https://marketontology.com/market-events/2026-09-17/exosens-raises-2026-ebitda-guidance-to-192m-on-image-intensifier-tube-ramp-1584d3
How this development reaches the affected companies
| Asset | Exposure and channel | Direction | Evidence |
|---|---|---|---|
| EXSNY | operating margin expansion via high-margin defense electro-optics production ramp | Up1-4w | Exosens raised 2026 revenue guidance to €558-570M and adjusted EBITDA to €186-192M on production ramp. |
Does this development affect your holdings?
Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
What happened next
Price follow-up pending — no stored daily closes for these assets yet.
Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.
No verifiable public source recorded for this card.
Related
- 2026-09-17Exosens Raises 2026 Revenue and EBITDA Guidance on Defense Production RampEXSNY
- 2026-09-17Exosens Raises 2026 Revenue and EBITDA Outlook on Production RampEXSNY
- 2026-09-17Exosens Raises 2026 Revenue and EBITDA Outlook on Production RampEXSNY
- 2026-09-17Exosens Raises 2026 Revenue and EBITDA Outlook on Production RampEXSNY
- 2026-09-17Exosens Raises 2026 EBITDA Guidance to €192M on Image Intensifier Tube RampEXSNY
- 2026-06-25Exosens Secures 140M Euro EIB Loan for European Defense InnovationEXSNY
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.